The Walgreens Boots Alliance, Inc. (WBA) Position Maintained by Chatham Capital Group Inc.

The Walgreens Boots Alliance, Inc. (WBA) Position Maintained by Chatham Capital Group Inc.

Other hedge funds have also recently modified their holdings of the company. Nordea Investment Management AB raised its stake in shares of Walgreens Boots Alliance by 26.5% in the first quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator’s stock worth $760,267,000 after buying an additional 1,917,082 shares during the period. UBS Asset Management Americas Inc. raised its stake in Walgreens Boots Alliance by 22.9% in the first quarter. UBS Asset Management Americas Inc. now owns 4,912,489 shares of the pharmacy operator’s stock valued at $407,982,000 after buying an additional 914,888 shares during the last quarter. Swiss National Bank raised its stake in Walgreens Boots Alliance by 27.3% in the first quarter. Swiss National Bank now owns 3,262,703 shares of the pharmacy operator’s stock valued at $270,967,000 after buying an additional 700,400 shares during the last quarter. Canada Pension Plan Investment Board raised its stake in Walgreens Boots Alliance by 28.9% in the first quarter. Canada Pension Plan Investment Board now owns 1,982,013 shares of the pharmacy operator’s stock valued at $164,606,000 after buying an additional 444,900 shares during the last quarter. Finally, Karp Capital Management Corp bought a new stake in Walgreens Boots Alliance during the first quarter valued at about $30,227,000. Institutional investors own 61.16% of the company’s stock.

Chatham Capital Group Inc. maintained its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,535 shares of the pharmacy operator’s stock at the end of the first quarter. Chatham Capital Group Inc.’s holdings in Walgreens Boots Alliance were worth $460,000 as of its most recent SEC filing.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 81.13 on Wednesday. Walgreens Boots Alliance, Inc. has a 52-week low of $75.18 and a 52-week high of $88.00. The stock has a 50 day moving average price of $78.82 and a 200 day moving average price of $82.40. The firm has a market cap of $86.82 billion, a P/E ratio of 20.49 and a beta of 1.25.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The firm had revenue of $30.12 billion for the quarter, compared to analysts’ expectations of $29.72 billion. During the same quarter last year, the firm earned $1.18 EPS. The company’s quarterly revenue was up 2.1% compared to the same quarter last year. Equities analysts predict that Walgreens Boots Alliance, Inc. will post $5.01 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th will be given a dividend of $0.40 per share. The ex-dividend date is Wednesday, August 16th. This represents a $1.60 annualized dividend and a dividend yield of 1.97%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 37.78%.

Walgreens Boots Alliance announced that its board has approved a share repurchase program on Wednesday, April 5th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to buy shares of its stock through open market purchases. Shares repurchase programs are often a sign that the company’s management believes its stock is undervalued.

Several analysts recently issued reports on WBA shares. Morgan Stanley reiterated an “overweight” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Guggenheim reiterated a “buy” rating and set a $100.00 target price on shares of Walgreens Boots Alliance in a report on Thursday, April 6th. Jefferies Group LLC reiterated a “buy” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a report on Thursday, April 6th. Citigroup Inc. reiterated a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Finally, Zacks Investment Research lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday, June 14th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and fourteen have assigned a buy rating to the stock. Walgreens Boots Alliance currently has a consensus rating of “Buy” and an average target price of $90.69.

In related news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the sale, the director now owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 13.50% of the stock is owned by company insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Related posts

Leave a Comment